Allogene Therapeutics Inc (ALLO)
Investing Cash Flow
-$131.60M
TTM · Period ending: · USD
ALLO Investing Cash Flow
Latest reported-$131.60Mperiod ending
Latest reported-$131.60Mperiod ending
ALLO TTM Cash from Investing (-$632.80M → -$131.60M)
TTM investing cash flow
High-resolution chart · PNG
ALLO investing cash flow history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Investing Cash Flow (USD) |
|---|---|
| -131,599,000 | |
| 59,795,000 | |
| 95,559,000 | |
| 116,880,000 | |
| 28,953,000 | |
| 59,731,000 | |
| 75,688,000 | |
| 88,215,000 | |
| 129,940,000 | |
| 72,487,000 | |
| 163,289,000 | |
| 145,425,000 | |
| 204,597,000 | |
| 241,471,000 | |
| 106,159,000 | |
| 85,812,000 | |
| 73,920,000 | |
| 44,480,000 | |
| 163,655,000 | |
| 156,615,000 | |
| 60,247,000 | |
| -393,318,000 | |
| -505,123,000 | |
| -519,404,000 | |
| -357,274,000 | |
| 116,189,000 | |
| 164,084,000 | |
| -157,233,000 | |
| -552,784,000 | |
| -599,910,000 | |
| -632,798,000 | |
| -319,410,000 |